Thyrocare board to weigh interim dividend, bonus shares, Q2 results

Thyrocare Technologies Limited has scheduled a board of directors meeting for Tuesday, October 14, 2025. The agenda includes considering and approving the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025.

Additionally, the board will deliberate on the declaration of an interim dividend for the financial year 2025-26 and a proposal for the issue of bonus shares. These actions are in accordance with the Companies Act, 2013, and SEBI regulations. The record date for determining eligible members for the interim dividend and bonus shares will be communicated separately.

The trading window for company equity shares has been closed since October 1, 2025, for designated persons and their immediate relatives, adhering to SEBI Insider Trading Regulations, 2015. It will reopen 48 hours after the declaration of the unaudited financial results for the quarter and half-year ended September 30, 2025.